体外反搏装置是一种无创伤的辅助循环装置,属于生物医学工程范畴。1953年Kantrcwiiz等首先提出了升高舒张压以增加冠状动脉血流灌注的设想和实验;1962年Moclopoulos成功地设计出主动脉内球囊反搏装置(内反搏)并将内反搏术应用于实验性急性心肌梗塞,证明能缩小心肌梗塞区的面积,提高动物存活率,1967年内反搏开始 Extracorporeal pacing device is a non-invasive auxiliary circulatory device, which belongs to the biomedical engineering category. In 1953, Kantrcwiiz et al first proposed the hypothesis and experiment of increasing diastolic blood pressure to increase coronary blood flow perfusion. In 1962, Moclopoulos successfully designed an intra-aortic balloon pump (ECB) and applied EECP In experimental acute myocardial infarction, proved to be able to reduce the area of ​​myocardial infarction area, improve animal survival, counterpulsation began in 1967